The ninth issue of BioMatters™, the only in-depth publication showcasing the range and vitality of Michigan’s biosciences industry, is now available.
This is a dynamic time in Michigan’s economy, and sharing information about our state’s health and biosciences industry is critical as we work to build upon our already significant strengths and define a new future.
Michigan’s bioscience community is vibrant and robust, with strengths and assets along the continuum—world-renowned academic research, emerging technology, medical device and diagnostic companies, global pharmaceuticals, mature bio-industry, and a strong support network. The state’s bioscience entrepreneurial ecosystem is rapidly evolving and bursting with innovation, growing investment, and superb talent. As a result, company growth continues unabated and successful exits are becoming routine.
BioMatters helps MichBio fulfill its mission in “driving bio-industry growth” by educating you about the discoveries, technologies, and products being researched, developed, and manufactured here in Michigan, and the many resources available to support those activities. As a whole, the economic impact of Michigan’s bio-industry is sizeable and its reach global.
This issue highlights the innovation emerging from large and small companies—as well as our academic and clinical research centers—and serves as a snapshot of Michigan’s outstanding biosciences community. Read how University of Michigan researchers and doctors are leading the creation and application of life-saving 3D-printed devices (p. 9). Learn how Beaumont, one of our state’s premier health systems, is developing new cardiovascular technologies to help patients who can’t be treated with conventional approaches (p. 11). Or follow the growth of various companies in the chemical, device, bio-analytic, genetic, and diagnostic technology areas as they pursue global markets with innovative products and services. Understand how expert providers assist start-ups and established companies in Michigan—and around the world—with product development and communications strategies targeted toward health providers and patients. Lastly, familiarize yourself with the State of Michigan’s innovative BioTrust for Health through which residual newborn blood spots are made available for important medical and public health research (p. 30).